Addiction

UNODC's Demand Reduction Standards Part 2 - Treatment & Harm Reduction

17 March 2021

Online

The VNGOC together with the UNODC Civil Society Unit will be holding a two-part series of webinars to present the International Standards on Drug Use Prevention, the International Standards on the T

Preparing an Addiction Study Program Based on Learning Outcomes

Video and audio recordings

Presenters Michal Miovsky and Anna Volfova discuss their implementation of learning outcomes in their addiction education program at Charles University in Prague.

Smoking Cessation for Improving Mental Health- Cochrane Review

Scientific article

People with mental health issues are more likely to smoke compared to the general population. They are also more likely to experience severe withdrawals and are less responsive to treatment. Indeed, some people believe that quitting smoking...

2021 Annual SRNT-E Conference

15 September 2021

Online

SRNT-E is the European chapter of the Society for Research on Nicotine and Tobacco.

The 2021 SRNT-E conference will be organised virtually on 15-17th September 2021.

Speakers will discuss the latest research on the following topics:

Society for the Study of Addiction (SSA) Professorship Scheme

News

The ‘SSA Addictions Professorship’ scheme aims to support individuals who are already senior academics with established expertise and who wish to move to become part of UK academic growth in addictions research, but who would face potential...

Adiktologie Journal Issue 3-4

Book

The Adiktologie Journal is the professional journal for research concerning the prevention and treatment of addiction. Below, you can find articles that make up the December 2020 edition. EDITORIAL From Prevention Programmes to Health...

A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy

Scientific article

16 November 2020

Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.